Benchmarking and Optimizing Pharmacologic Restraint for Agitated Youth in the Emergency Medicine Department - 23/08/21
Doi : 10.1016/j.jpeds.2021.04.039
Jennifer L. Vande Voort, MD ⁎ 
, Paul E. Croarkin, DO, MS
, Paul E. Croarkin, DO, MS Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN
∗Reprint requests: Jennifer L. Vande Voort, MD, Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905Department of Psychiatry and PsychologyMayo Clinic200 First Street SWRochesterMN55905
Le texte complet de cet article est disponible en PDF.
| J.V.V. is a primary investigator on an investigator-initiated study that has a grant-in-kind for supplies and genotyping only through Assurex Health, Inc. She is also on the Editorial Board of The Journal of Pediatrics. P.C. has received research grant support from Neuronetics, Inc, and NeoSync, Inc. He has received grant-in-kind support (equipment support for research studies) from Neuronetics, Inc, and MagVenture, Inc. He has received grant-in-kind support from Assurex Health, Inc, for supplies and genotyping. He has served as a consultant for Myriad Neuroscience, Procter & Gamble, and Sunovion. |
© 2021
Elsevier Inc. Tous droits réservés.
Vol 236
P. 8-9 - septembre 2021 Retour au numéro
Article précédent
- Transitional Leadership: Three Leader's Perspectives on an Increasingly Common Position
- Allison S. McBride, Evelyn Y. Anthony, Julie A. Freischlag
- What Will it Take to Achieve Routine Screening for Abuse?
- Daniel M. Lindberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?